Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22344

1.

Progress toward a Universal H5N1 Vaccine: A Recombinant Modified Vaccinia Virus Ankara-Expressing Trivalent Hemagglutinin Vaccine.

Prabakaran M, Leyrer S, He F, Auer S, Kumar SR, Kindsmueller K, Mytle N, Schneider J, Lockhart S, Kwang J.

PLoS One. 2014 Sep 17;9(9):e107316. doi: 10.1371/journal.pone.0107316. eCollection 2014.

PMID:
25229722
[PubMed - in process]
Free Article
2.

Asymptomatic HIV-infected Individuals on Antiretroviral Therapy Exhibit Impaired Lung CD4+ T Cell Responses to Mycobacteria.

Jambo KC, Banda DH, Afran L, Kankwatira AM, Malamba RD, Allain TJ, Gordon SB, Heyderman RS, Russell DG, Mwandumba HC.

Am J Respir Crit Care Med. 2014 Sep 16. [Epub ahead of print]

PMID:
25225948
[PubMed - as supplied by publisher]
3.

Safety of Live-Attenuated Influenza Vaccination in Cystic Fibrosis.

Boikos C, De Serres G, Lands LC, Boucher FD, Tapiéro B, Daigneault P, Quach C.

Pediatrics. 2014 Sep 15. pii: peds.2014-0887. [Epub ahead of print]

PMID:
25225145
[PubMed - as supplied by publisher]
4.

Targeting the C-type Lectins-Mediated Host-Pathogen Interactions with Dextran.

Pustylnikov S, Sagar D, Jain P, Khan ZK.

J Pharm Pharm Sci. 2014;17(3):371-92.

PMID:
25224349
[PubMed - in process]
5.

Vaccination recommendations for patients with neuromuscular disease.

Esposito S, Bruno C, Berardinelli A, Filosto M, Mongini T, Morandi L, Musumeci O, Pegoraro E, Siciliano G, Tonin P, Marrosu G, Minetti C, Servida M, Fiorillo C, Conforti G, Scapolan S, Ansaldi F, Vianello A, Castaldi S, Principi N, Toscano A, Moggio M.

Vaccine. 2014 Sep 12. pii: S0264-410X(14)01235-3. doi: 10.1016/j.vaccine.2014.09.003. [Epub ahead of print]

PMID:
25223270
[PubMed - as supplied by publisher]
6.

Influenza vaccine effectiveness estimates for Western Australia during a period of vaccine and virus strain stability, 2010 to 2012.

Levy A, Sullivan SG, Tempone S, Wong KL, Regan A, Dowse GK, Effler P, Smith D.

Vaccine. 2014 Sep 12. pii: S0264-410X(14)01224-9. doi: 10.1016/j.vaccine.2014.08.066. [Epub ahead of print]

PMID:
25223268
[PubMed - as supplied by publisher]
7.

Enhanced and persistent antibody response against homologous and heterologous strains elicited by a MF59®-adjuvanted influenza vaccine in infants and young children.

Nolan T, Bravo L, Ceballos A, Mitha E, Gray G, Quiambao B, Patel SS, Bizjajeva S, Bock H, Nazaire-Bermal N, Forleo-Neto E, Cioppa GD, Narasimhan V.

Vaccine. 2014 Sep 12. pii: S0264-410X(14)01226-2. doi: 10.1016/j.vaccine.2014.08.068. [Epub ahead of print]

PMID:
25223266
[PubMed - as supplied by publisher]
8.

Clinical and Immune Responses to Inactivated Influenza A(H1N1)pdm09 Vaccine in Children.

Kotloff KL, Halasa NB, Harrison CJ, Englund JA, Walter EB, King JC, Creech CB, Healy SA, Dolor RJ, Stephens I, Edwards KM, Noah DL, Hill H, Wolff M.

Pediatr Infect Dis J. 2014 Aug;33(8):865-71. doi: 10.1097/INF.0000000000000329.

PMID:
25222307
[PubMed - in process]
9.

TLR5-Mediated Sensing of Gut Microbiota Is Necessary for Antibody Responses to Seasonal Influenza Vaccination.

Oh JZ, Ravindran R, Chassaing B, Carvalho FA, Maddur MS, Bower M, Hakimpour P, Gill KP, Nakaya HI, Yarovinsky F, Sartor RB, Gewirtz AT, Pulendran B.

Immunity. 2014 Sep 9. pii: S1074-7613(14)00303-3. doi: 10.1016/j.immuni.2014.08.009. [Epub ahead of print]

PMID:
25220212
[PubMed - as supplied by publisher]
10.

Evaluation of a fully human monoclonal antibody against multiple Influenza A viral strains in mice and a pandemic H1N1 strain in nonhuman primates.

Song A, Myojo K, Laudenslager J, Harada D, Miura T, Suzuki K, Kuni-Kamochi R, Soloff R, Ohgami K, Kanda Y.

Antiviral Res. 2014 Sep 10. pii: S0166-3542(14)00253-8. doi: 10.1016/j.antiviral.2014.08.016. [Epub ahead of print]

PMID:
25218949
[PubMed - as supplied by publisher]
11.

Comparative analysis of virulence of a novel, avian-origin H3N2 canine influenza virus in various host species.

Lyoo KS, Kim JK, Kang B, Moon H, Kim J, Song M, Park B, Kim SH, Webster RG, Song D.

Virus Res. 2014 Sep 12. pii: S0168-1702(14)00348-7. doi: 10.1016/j.virusres.2014.08.020. [Epub ahead of print]

PMID:
25218482
[PubMed - as supplied by publisher]
12.

Novel vector vaccine against Brucella abortus based on influenza A viruses expressing Brucella L7/L12 or Omp16 proteins: Evaluation of protection in pregnant heifers.

Tabynov K, Yespembetov B, Sansyzbay A.

Vaccine. 2014 Sep 10. pii: S0264-410X(14)01231-6. doi: 10.1016/j.vaccine.2014.08.073. [Epub ahead of print]

PMID:
25218295
[PubMed - as supplied by publisher]
13.

Health care professionals' awareness of, knowledge about and attitude to influenza vaccination.

Alshammari TM, AlFehaid LS, AlFraih JK, Aljhadey HS.

Vaccine. 2014 Sep 9. pii: S0264-410X(14)01219-5. doi: 10.1016/j.vaccine.2014.08.061. [Epub ahead of print]

PMID:
25218193
[PubMed - as supplied by publisher]
14.

Energetic changes caused by antigenic module insertion in a virus-like particle revealed by experiment and molecular dynamics simulations.

Zhang L, Tang R, Bai S, Connors NK, Lua LH, Chuan YP, Middelberg AP, Sun Y.

PLoS One. 2014 Sep 12;9(9):e107313. doi: 10.1371/journal.pone.0107313. eCollection 2014.

PMID:
25215874
[PubMed - in process]
Free PMC Article
15.

Recombinant influenza H7 hemagglutinins induce lower neutralizing antibody titers in mice than do seasonal hemagglutinins.

Blanchfield K, Kamal RP, Tzeng WP, Music N, Wilson JR, Stevens J, Lipatov AS, Katz JM, York IA.

Influenza Other Respir Viruses. 2014 Sep 12. doi: 10.1111/irv.12285. [Epub ahead of print]

PMID:
25213778
[PubMed - as supplied by publisher]
16.

Maximal immune response and cross protection by influenza virus nucleoprotein derived from E. coli using an optimized formulation.

Wang W, Huang B, Jiang T, Wang X, Qi X, Tan W, Ruan L.

Virology. 2014 Sep 8;468-470C:265-273. doi: 10.1016/j.virol.2014.08.008. [Epub ahead of print]

PMID:
25213406
[PubMed - as supplied by publisher]
17.

Full-Genome Sequence Analysis of a Natural Reassortant H4N2 Avian Influenza Virus Isolated from a Domestic Duck in Southern China.

Wu A, Xie Z, Xie L, Xie Z, Luo S, Deng X, Huang L, Huang J, Zeng T.

Genome Announc. 2014 Sep 11;2(5). pii: e00894-14. doi: 10.1128/genomeA.00894-14.

PMID:
25212619
[PubMed]
Free Article
18.

Safety and immunogenicity profiles of an adjuvanted seasonal influenza vaccine in Guatemalan children.

Solares AR, Aragon CG, Pivaral RU, Prado-Cohrs D, Sales-Carmona V, Pellegrini M, Groth N.

J Infect Dev Ctries. 2014 Sep 12;8(9):1160-8. doi: 10.3855/jidc.4594.

PMID:
25212080
[PubMed - in process]
Free Article
19.

Progress toward the development of universal influenza vaccines.

Hoft DF, Belshe RB.

Mo Med. 2014 Jul-Aug;111(4):321-5.

PMID:
25211862
[PubMed - in process]
20.

Protective Efficacy of a Single Dose of Baculovirus Hemagglutinin-Based Vaccine in Chickens and Ducks Against Homologous and Heterologous H5N1 Virus Infections.

Park EH, Song BM, Yum J, Kim JA, Oh SK, Kim HS, Cho GJ, Seo SH.

Viral Immunol. 2014 Sep 11. [Epub ahead of print]

PMID:
25211640
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk